Alnylam Pharmaceuticals: Balancing Promising Pipeline With Competitive Challenges and Strategic Uncertainties

TipRanks04:37 ET

Here's How Much You Would Have Made Owning Alnylam Pharmaceuticals Stock In The Last 20 Years

Benzinga15:00 ET

BMO Capital Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $300

Moomoo NewsFeb 26 08:31 ET · Ratings

TD Cowen Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $371

Moomoo NewsFeb 26 08:31 ET · Ratings

Stifel Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Raises Target Price to $300

Moomoo NewsFeb 26 08:31 ET · Ratings

Alnylam Pharmaceuticals Is Maintained at Buy by Chardan Capital

Dow JonesFeb 26 08:17 ET · Ratings